<DOC>
	<DOCNO>NCT00690924</DOCNO>
	<brief_summary>RATIONALE : Calcitriol may prevent lung cancer patient metaplasia dysplasia lung . PURPOSE : This clinical trial study side effect best dose calcitriol prevent lung cancer current smoker former smoker high risk lung cancer .</brief_summary>
	<brief_title>Calcitriol Preventing Lung Cancer Smokers Former Smokers High Risk Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - To establish safety calcitriol patient high risk lung cancer . - To determine dose-limiting toxicity calcitriol patient . OUTLINE : Patients receive oral calcitriol day 1 . Courses repeat every 2 week 3 month absence unacceptable toxicity . Patients undergo blood collection periodically pharmacokinetic molecular analysis . After completion study therapy , patient follow periodically .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Precancerous Conditions</mesh_term>
	<mesh_term>Calcitriol</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Pathologically confirm squamous metaplasia squamous dysplasia lung autofluorescence bronchoscopy within past 5 year Must current former smoker No evidence concurrent disease lung cancer head neck cancer History treat lung cancer head neck cancer treat curative intent allow , provide evidence disease &gt; 1 year PATIENT CHARACTERISTICS : ECOG performance status 01 Total granulocyte count &gt; 1,500 x 10^9cells/L Platelet count &gt; 100,000 x 10^9cells/L Calculated Creatinine clearance &gt; 60 mL/min ( use CockcroftGault formula ) Calcium concentration 50300 mg/24 hour Total bilirubin 0.21.3 mg % ALT/AST ≤ 2.5 time upper limit normal ( ULN ) Alkaline phosphatase ≤ 2.5 time ULN Albumin ≥ 2.5 g/dL Ionized serum calcium normal ( 1.191.29 mmol/L ) Corrected serum calcium ≤ 10.2 mg/dL Willing attend schedule study visit , complete study questionnaire , allow biological specimen collection , include bronchoscopy Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception least 1 month completion study therapy No lifethreatening medical condition would preclude bronchoscopy , include limited , follow : Acute cardiac failure Uncontrolled hypertension Uncontrolled diabetes mellitus Unstable coronary artery disease No severe metabolic disorder would preclude calcitriol administration No history malignancy within 3 year except nonmelanoma skin cancer cervical carcinoma situ No history evidence kidney stone No patient susceptible calciumrelated dysrhythmias No known hypersensitivity calcitriol No known allergy tree nut ( i.e. , almond ) PRIOR CONCURRENT THERAPY : At least 2 month since prior concurrent calcium supplement Concurrent multivitamin supplement allow provided amount vitamin D supplement excess recommend daily dose No concurrent thiazide , phenobarbital , digitalis No concurrent digoxin No concurrent bile acid bind drug ( i.e. , cholestyramine , colestipol ) No concurrent danazol aluminumbased antacid No concurrent ketoconazole azole antifungal</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>lung cancer</keyword>
	<keyword>tobacco use disorder</keyword>
	<keyword>squamous lung dysplasia</keyword>
</DOC>